AstraZeneca’s JUPITER Study Brings Challenges For Crestor Marketing
Executive Summary
AstraZeneca and its cholesterol-lowering agent Crestor scored a clear coup Nov. 9, when results of the widely-publicized JUPITER trial were announced at the American Heart Association meeting. The firm's ability to maximize the potential of the findings, however, presents multiple marketing challenges